BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2020
View Archived Issues
Biotest submits phase II study of trimodulin for severe COVID-19 in Spain
Read More
Centivax antibody shows potential as therapeutic and prophylactic in models of COVID-19
Read More
SMYD3 could be a potential therapeutic target in HNSCC
Read More
FDA reviews pre-IND application for Tetra's ARDS-003 to prevent COVID-19-related ARDS
Read More
PRX-034 and its prodrug PRX-007 as promising candidates for the treatment of cancer and COVID-19
Read More
Novel mouse model of prostate cancer to evaluate chemopreventive potential of pterostilbene
Read More
Shanghai Zheye Biotechnology patents ACVR1 inhibitors
Read More
Sichuan Kelun-Biotech Biopharmaceutical discloses adenosine A2A receptor antagonists
Read More
Chinese researchers divulge hSTING agonists
Read More
Carragelose shows efficacy against SARS-CoV-2 in cell culture assays
Read More
Medshine Discovery identifies FGFR and VEGFR dual inhibitors
Read More
68Ga-radiolabeled peptide targeting integrin alpha3beta1 developed to image pancreatic cancer
Read More
Hangzhou Bio-Creativity Pharma-Tech divulges CDK inhibitors
Read More
Positive preclinical results reported for LineaDNA COVID-19 vaccine candidates
Read More
Using red blood cells, EDITing strengthens immune response
Read More
Protein degradation system targeted to KRAS
Read More
First patient dosed in phase I/II study of bemcentinib in GBM
Read More
Antibody fragment-drug conjugates investigated as alternative to antibody-drug conjugates
Read More
Kringle begins phase III trial of KP-100IT for acute spinal cord injury in Japan
Read More
Synairgen reports promising data from SNG-001 trial in hospitalized COVID-19 patients
Read More
PLAC8 unveiled as a marker of chemoresistance in PSTT and choriocarcinoma
Read More
GSK initiates phase I study of S. aureus vaccine candidate GSK-3878858-A
Read More
Silverback begins first-in-human study of SBT-6050 in advanced HER2 solid tumors
Read More
Sage Therapeutics studies SAGE-324 in phase II for essential tremor
Read More
NFlection opens phase IIa study of NFX-179 for cutaneous neurofibromas
Read More